Koninklijke DSM NV (DSM.AS) Stock Price, Forecast & Analysis
Europe - Euronext Amsterdam - AMS:DSM - NL0000009827 - Common Stock
DSM.AS Key Statistics, Chart & Performance
The current stock price of DSM.AS is 114.05 EUR. In the past month the price increased by 1.11%. In the past year, price decreased by -27.19%.
DSM.AS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1COV.DE | COVESTRO AG | N/A | 11.34B | ||
| AKZA.AS | AKZO NOBEL N.V. | 16.07 | 10.00B | ||
| AKU1.DE | AKZO NOBEL N.V. | 16.02 | 9.97B | ||
| SY1.DE | SYMRISE AG | 18.84 | 9.56B | ||
| SYENS.BR | SYENSQO SA | 20.89 | 7.05B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.64 | 6.11B | ||
| UMI.BR | UMICORE | 15.81 | 4.40B | ||
| NVJP.DE | UMICORE | 15.81 | 4.40B | ||
| AKE.PA | ARKEMA | 9.9 | 3.88B | ||
| WCH.DE | WACKER CHEMIE AG | 154.88 | 3.47B | ||
| RBT.PA | ROBERTET SA | 18.59 | 1.89B | ||
| ACT.DE | ALZCHEM GROUP AG | 23.8 | 1.48B |
Related stock screener links
About DSM.AS
Company Profile
Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company is headquartered in Heerlen, Limburg and currently employs 20,682 full-time employees. The firm's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.
Company Info
Koninklijke DSM NV
Het Overloon 1
Heerlen LIMBURG NL
Employees: 20682
Phone: 31455788111.0
Koninklijke DSM NV / DSM.AS FAQ
What does Koninklijke DSM NV do?
Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company is headquartered in Heerlen, Limburg and currently employs 20,682 full-time employees. The firm's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.
Can you provide the latest stock price for Koninklijke DSM NV?
The current stock price of DSM.AS is 114.05 EUR. The price increased by 0.13% in the last trading session.
Does DSM stock pay dividends?
Koninklijke DSM NV (DSM.AS) has a dividend yield of 2.31%. The yearly dividend amount is currently 1.99.
What is the ChartMill technical and fundamental rating of DSM stock?
DSM.AS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
On which exchange is DSM.AS stock listed?
DSM.AS stock is listed on the Euronext Amsterdam exchange.
Who owns Koninklijke DSM NV?
You can find the ownership structure of Koninklijke DSM NV (DSM.AS) on the Ownership tab.
DSM.AS Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to DSM.AS. When comparing the yearly performance of all stocks, DSM.AS is a bad performer in the overall market: 86.44% of all stocks are doing better.
DSM.AS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DSM.AS. DSM.AS has only an average score on both its financial health and profitability.
DSM.AS Financial Highlights
Over the last trailing twelve months DSM.AS reported a non-GAAP Earnings per Share(EPS) of 9.8. The EPS increased by 1.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.19% | ||
| ROA | 9.73% | ||
| ROE | 15.77% | ||
| Debt/Equity | 0.28 |
DSM.AS Forecast & Estimates
24 analysts have analysed DSM.AS and the average price target is 151.14 EUR. This implies a price increase of 32.52% is expected in the next year compared to the current price of 114.05.
For the next year, analysts expect an EPS growth of -17.84% and a revenue growth 9.64% for DSM.AS